CC, G., D, A., T, R., A, S., K, S., S, J., . . . J, A. (2016). Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis. Neurology(R) neuroimmunology & neuroinflammation, 3(6), e289. https://doi.org/10.1212/NXI.0000000000000289
Chicago Style (17th ed.) CitationCC, Gross, et al. "Alemtuzumab Treatment Alters Circulating Innate Immune Cells in Multiple Sclerosis." Neurology(R) Neuroimmunology & Neuroinflammation 3, no. 6 (2016): e289. https://doi.org/10.1212/NXI.0000000000000289.
MLA (9th ed.) CitationCC, Gross, et al. "Alemtuzumab Treatment Alters Circulating Innate Immune Cells in Multiple Sclerosis." Neurology(R) Neuroimmunology & Neuroinflammation, vol. 3, no. 6, 2016, p. e289, https://doi.org/10.1212/NXI.0000000000000289.